LU91406I2 - Anidulafungine, optionnellement sous forme d'un sel pharmaceutiquement acceptable -ECALTA - Google Patents

Anidulafungine, optionnellement sous forme d'un sel pharmaceutiquement acceptable -ECALTA

Info

Publication number
LU91406I2
LU91406I2 LU91406C LU91406C LU91406I2 LU 91406 I2 LU91406 I2 LU 91406I2 LU 91406 C LU91406 C LU 91406C LU 91406 C LU91406 C LU 91406C LU 91406 I2 LU91406 I2 LU 91406I2
Authority
LU
Luxembourg
Prior art keywords
hydrogen
ecalta
anidulafungin
optionally
pharmaceutically acceptable
Prior art date
Application number
LU91406C
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU91406I2 publication Critical patent/LU91406I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/66—Gramicidins S, C; Tyrocidins A, B, C; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
LU91406C 1992-03-19 2008-01-09 Anidulafungine, optionnellement sous forme d'un sel pharmaceutiquement acceptable -ECALTA LU91406I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85411792A 1992-03-19 1992-03-19
US99239092A 1992-12-16 1992-12-16

Publications (1)

Publication Number Publication Date
LU91406I2 true LU91406I2 (fr) 2008-03-10

Family

ID=27127211

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91406C LU91406I2 (fr) 1992-03-19 2008-01-09 Anidulafungine, optionnellement sous forme d'un sel pharmaceutiquement acceptable -ECALTA

Country Status (25)

Country Link
EP (1) EP0561639B1 (fr)
JP (3) JP3519754B2 (fr)
KR (1) KR100256036B1 (fr)
CN (1) CN1036715C (fr)
AT (1) ATE217635T1 (fr)
AU (2) AU3534193A (fr)
BR (1) BR9301232A (fr)
CA (1) CA2091663C (fr)
CZ (1) CZ288974B6 (fr)
DE (2) DE122008000006I2 (fr)
DK (1) DK0561639T3 (fr)
ES (1) ES2174843T3 (fr)
FI (1) FI118768B (fr)
HU (2) HU225783B1 (fr)
IL (3) IL122315A (fr)
LU (1) LU91406I2 (fr)
MX (1) MX9301457A (fr)
MY (1) MY136593A (fr)
NL (1) NL300334I2 (fr)
NO (1) NO930948L (fr)
NZ (3) NZ512085A (fr)
PT (1) PT561639E (fr)
RU (1) RU2129562C1 (fr)
TW (1) TW264477B (fr)
YU (1) YU49108B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
IL122315A (en) * 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
CA2161149A1 (fr) * 1993-05-04 1994-11-10 James M. Balkovec Ether-oxydes de cyclohexapeptidyle et d'aminoalkyle
WO1995008341A1 (fr) * 1993-09-22 1995-03-30 Merck & Co., Inc. Composes antifongiques et anti-pneumocystose, compositions les contenant et procedes d'utilisation
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen
AU696949B2 (en) * 1994-10-07 1998-09-24 Astellas Pharma Inc. Cyclic hexapeptides having antibiotic activity
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
AU691743B2 (en) * 1995-01-26 1998-05-21 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629289A (en) * 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5693611A (en) * 1996-02-01 1997-12-02 Eli Lilly And Company Cyclic peptide antifungal agents
JP2001503015A (ja) * 1996-02-01 2001-03-06 イーライ・リリー・アンド・カンパニー 環状ペプチド抗真菌剤
JPH09227422A (ja) * 1996-02-12 1997-09-02 Rolic Ag シクロペンチル誘導体
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003200556B2 (en) * 1997-12-10 2005-12-01 Novexel Echinocandin derivative and their preparation method
UA72200C2 (uk) * 1997-12-10 2005-02-15 Авентіс Фарма С.А. Похідні ехінокандину, спосіб їх одержання, їх застосування, проміжні сполуки та фармацевтична композиція
FR2784993B1 (fr) * 1998-10-26 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme fongicides
WO1999047551A1 (fr) * 1998-03-16 1999-09-23 Fujisawa Pharmaceutical Co., Ltd. Wf14573 ou son sel et procedes de fabrication et d'utilisation correspondants
DK1107981T3 (da) 1998-08-20 2005-05-30 Lilly Co Eli Syntese af ringmodificerede, cykliske peptidanaloger
DK1137663T3 (da) 1998-12-09 2007-01-08 Lilly Co Eli Oprensning af Echinocandin-cyclopeptidforbindelser
DE19907904A1 (de) 1999-02-24 2000-08-31 Clariant Gmbh Verfahren zur Herstellung von [1,1':4',1"]-Terphenylverbindungen
ES2270819T3 (es) 1999-03-03 2007-04-16 Eli Lilly And Company Formacion e intercambio anionico de sales de amonio internas cristalinas de equinocandina.
CN100335122C (zh) * 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂
AU772633B2 (en) 1999-03-03 2004-05-06 Eli Lilly And Company Echinocandin/carbohydrate complexes
CA2362482A1 (fr) 1999-03-03 2000-09-08 Eli Lilly And Company Procedes permettant de preparer des compositions et des formulations pharmaceutiques orales d'echinocandine b
AU2001232319B2 (en) * 2000-02-18 2005-01-13 Meiji Seika Kaisha, Ltd. Phenoxyalkylamine derivates useful as opioid delta receptor ligands
FR2833596B1 (fr) * 2001-12-14 2005-02-18 Aventis Pharma Sa Procede de preparation de derives d'echinocandine
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
JP2006525365A (ja) * 2003-04-30 2006-11-09 ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー フェニル置換カルボン酸
KR101551207B1 (ko) * 2008-09-04 2015-09-08 롬엔드하스전자재료코리아유한회사 신규한 유기 발광 화합물 및 이를 발광재료로서 채용하고 있는 유기 발광 소자
CN102464704B (zh) * 2010-11-05 2013-12-11 上海医药工业研究院 一种化合物及其制备方法和用途
RS59960B1 (sr) * 2012-03-19 2020-03-31 Cidara Therapeutics Inc Dozni režimi za jedinjenja klase ehinokandina
PL3058958T3 (pl) 2015-02-23 2019-02-28 Selectchemie Ag Kompozycja anidulafunginy
JP6866583B2 (ja) * 2016-07-05 2021-04-28 Dic株式会社 液晶化合物
CN116903706B (zh) * 2023-06-13 2024-05-17 深圳市祥根生物有限公司 一种棘白菌素类药物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE886576A (fr) * 1979-12-13 1981-06-10 Lilly Co Eli Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
BE886575A (fr) * 1979-12-13 1981-06-10 Lilly Co Eli Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
CA2037957A1 (fr) * 1990-03-12 1991-09-13 Merck & Co., Inc. Composes de cyclohexapeptides n-acyles
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
IL97347A0 (en) * 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
IL122315A (en) * 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ATE217635T1 (de) 2002-06-15
NZ247149A (en) 1996-10-28
IL105048A0 (en) 1993-07-08
ES2174843T3 (es) 2002-11-16
EP0561639A1 (fr) 1993-09-22
KR930019694A (ko) 1993-10-18
JP3519754B2 (ja) 2004-04-19
NO930948D0 (no) 1993-03-16
FI931202A (fi) 1993-09-20
YU18593A (sh) 1996-10-09
YU49108B (sh) 2004-03-12
NL300334I2 (nl) 2008-05-01
NO930948L (no) 1993-09-20
JP2004115540A (ja) 2004-04-15
IL122315A0 (en) 1998-04-05
JPH0656892A (ja) 1994-03-01
CZ41693A3 (en) 1994-07-13
AU6552996A (en) 1996-12-05
EP0561639B1 (fr) 2002-05-15
HU211562A9 (en) 1995-12-28
IL105048A (en) 2001-06-14
NZ512085A (en) 2003-08-29
CA2091663A1 (fr) 1993-09-20
IL122315A (en) 2002-03-10
HUT63637A (en) 1993-09-28
CN1080926A (zh) 1994-01-19
CA2091663C (fr) 2007-10-30
PT561639E (pt) 2002-10-31
BR9301232A (pt) 1993-09-21
KR100256036B1 (ko) 2000-05-01
NZ299314A (en) 2001-09-28
NL300334I1 (nl) 2008-03-03
MY136593A (en) 2008-10-31
CZ288974B6 (cs) 2001-10-17
JP2002226500A (ja) 2002-08-14
DE69331922T2 (de) 2002-08-29
CN1036715C (zh) 1997-12-17
DE69331922D1 (de) 2002-06-20
FI118768B (fi) 2008-03-14
AU3534193A (en) 1993-09-23
HU9300785D0 (en) 1993-06-28
FI931202A0 (fi) 1993-03-18
HU225783B1 (en) 2007-09-28
AU689391B2 (en) 1998-03-26
RU2129562C1 (ru) 1999-04-27
JP3520071B2 (ja) 2004-04-19
DE122008000006I1 (de) 2008-04-17
TW264477B (fr) 1995-12-01
DE122008000006I2 (de) 2011-07-21
DK0561639T3 (da) 2002-06-17
MX9301457A (es) 1994-02-28

Similar Documents

Publication Publication Date Title
LU91406I2 (fr) Anidulafungine, optionnellement sous forme d'un sel pharmaceutiquement acceptable -ECALTA
LU91112I2 (fr) Pregabalin, facultativement sous forme d'un sel pharmaceutiquement acceptable.
NZ332136A (en) Phenylalkylcarboxylic acid derivatives useful for treating hyperglycemia
PL304863A1 (en) Phenylalkanoamine derivatives, method of obtaining such derivatives and therapeutic agents containing them
EP0285284A3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
EP0555479A4 (fr)
TW275629B (fr)
PL329315A1 (en) Derivatives of phenylethanolaminotetralincarboxamide
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
CA2238710A1 (fr) Nouveaux derives d'aminoalcools, leur procede de production et medicaments contenant ces composes
JO1755B1 (en) Therapeutic agents